Search Result "dalcetrapib"
Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 2 Year: 2012 Page: 102-110
Author(s): Raktim Kumar Ghosh, Samhati Mondal Ghosh
CETP Pharmacological Manipulation Transforming Human into Mouse: Is this Still a Viable Hypothesis?
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 12 Issue: 4 Year: 2012 Page: 266-278
Author(s): Enrique Morales-Villegas,Gualberto Moreno-Virgen,Philip J. Barter
Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease
Journal: Current Vascular Pharmacology
Volume: 10 Issue: 6 Year: 2012 Page: 720-724
Author(s): Thomas F. Luscher,Arnold von Eckardstein,Branko Simic
The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3143-3149
Author(s): A.E. Bochem, J.A. Kuivenhoven, E.S.G. Stroes
Lipid and Apoprotein Composition of HDL in Partial or Complete CETP Deficiency
Journal: Current Vascular Pharmacology
Volume: 10 Issue: 4 Year: 2012 Page: 422-431
Author(s): Eric J. Niesor,Elisabeth von der Mark,Laura Calabresi,Maurizio Averna,Angelo B. Cefalu,Patrizia Tarugi,Peter Nilsson,Gregor Dernick
High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 1 Year: 2010 Page: 1480-1493
Author(s): Christian Besler, Kathrin Heinrich, Meliana Riwanto, Thomas F. Luscher, Ulf Landmesser
Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 871-876
Author(s): Klaus G. Parhofer
Cholesteryl Ester Transfer Protein (CETP) Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 9 Issue: 5 Year: 2009 Page: 419-427
Author(s): Julianne A. Hunt, Zhijian Lu
Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 5 Year: 2016 Page: 595-608
Author(s):
Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3841-3857
Author(s): Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano